TheEdgeResearch
Home / Stocks / GRIN.CN

Grown Rogue International Inc. (GRIN.CN)

CNQ Healthcare Drug Manufacturers - Specialty & Generic
$0.64 ▲ +1.59%
Market Cap
$160.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-1.04
52-Wk Range
0.38-0.72
CEO
J. Obie Strickler
Country
US
Currency
CAD

Grown Rogue International Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Medford, OR, US. The stock last traded at $0.64, up 1.59% on the session, giving a market capitalisation of $160.0M. Its beta of -1.04 implies it has historically moved less than the broad market.

Company profile
Exchange
Canadian Securities Exchange
Employees
204
IPO date
2016-11-28
Headquarters
Medford, OR, US
About Grown Rogue International Inc.

Grown Rogue International Inc., operating through its various subsidiaries, specializes in the cultivation and distribution of diverse cannabis products across the United States. Its comprehensive product portfolio features an assortment of cannabis flower strains, including popular indica, sativa, and hybrid varieties. Additionally, the company offers edibles, vape cartridges, convenient pre-rolled joints, and concentrated extracts. These goods are marketed to consumers through licensed dispensaries. Grown Rogue International Inc.'s corporate headquarters are situated in Medford, Oregon.

Comparable companies

Grown Rogue International Inc. is most often compared with the following Healthcare names:

BNXT.CNCRDL.TODB.VJUSH.CNLOVE.VMDP.TOMSCL.TOPLTH.CNRX.VZEN.V
More research on GRIN.CN
GRIN.CN technical analysis GRIN.CN TheEdge Score Compare against peers
Open full interactive analysis & DCF →